BioCentury
ARTICLE | Company News

Juvantia, Santhera Pharmaceutical Holdings AG deal

August 24, 2009 7:00 AM UTC

Santhera exercised an option to acquire Juvantia in a stock deal valued at CHF2.9 million ($2.7 million) based on Santhera's close of CHF27.50 on Aug. 14, the last trading day before the deal was anno...